MarketCap
Facebook
X
Telegram
Land |
 Deuschland |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
122 M |
Marktkapitalisierung |
$ 876 M |
EBITDA (LTM) |
$ -300 M |
P/E (LTM) |
-5.42 |
P/S (LTM) |
- |
EPS (LTM) |
-2.1 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Exicure
XCUR
|
$ 1.09 | 3.81 % | $ 6.86 M | Nasdaq Capital Market |  USA |
 |
Cellectis S.A.
CLLS
|
$ 0.95 | -3.3 % | $ 95.3 M | Nasdaq Global Market |  France |
 |
AbCellera Biologics
ABCL
|
$ 12.03 | 1.78 % | $ 3.59 B | Nasdaq Global Select Market |  Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 58.93 | 1.57 % | $ 7.88 B | Nasdaq Global Select Market,SPB | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 55.62 | -0.59 % | $ 10.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Celldex Therapeutics
CLDX
|
$ 29.48 | 0.79 % | $ 1.96 B | Nasdaq Global Select Market | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
$ 3.75 | 2.18 % | $ 45.8 M | Nasdaq Capital Market |  Israel |
 |
Jaguar Health
JAGX
|
$ 2.36 | 15.44 % | $ 5.5 M | Nasdaq Capital Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.49 | -2.35 % | $ 196 M | NYSE American | Israel |
 |
uniQure N.V.
QURE
|
$ 21.65 | -3.5 % | $ 1.24 B | Nasdaq Global Select Market |  Niderland |
 |
Stoke Therapeutics
STOK
|
$ 25.41 | 1.48 % | $ 1.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Xencor
XNCR
|
$ 29.2 | 15.95 % | $ 2.17 B | Nasdaq Global Select Market,SPB | USA |
 |
Annexon
ANNX
|
$ 3.71 | -1.2 % | $ 575 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.71 | -4.21 % | $ 2.82 M | NYSE American | Israel |
 |
Incyte Corporation
INCY
|
$ 113.3 | -2.08 % | $ 22.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Mesoblast Limited
MESO
|
$ 12.43 | 1.22 % | $ 15 B | Nasdaq Global Select Market |  Australia |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.2 | -0.16 % | $ 740 M | Nasdaq Global Select Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 516.39 | -1.44 % | $ 132 B | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 3.24 | -3.72 % | $ 710 M | NYSE |  Britain |
 |
Catalyst Biosciences
CBIO
|
$ 12.77 | -0.39 % | $ 1.14 B | Nasdaq Capital Market | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 25.47 | 1.29 % | $ 1.19 B | Nasdaq Global Select Market | USA |
 |
Anika Therapeutics
ANIK
|
$ 21.19 | -1.07 % | $ 304 M | Nasdaq Global Select Market,SPB | USA |
 |
Editas Medicine
EDIT
|
$ 2.4 | 0.05 % | $ 213 M | Nasdaq Global Select Market,SPB | USA |
 |
Evogene Ltd.
EVGN
|
$ 0.37 | 0.44 % | $ 2.91 M | Nasdaq Global Market | Israel |
 |
EyePoint Pharmaceuticals
EYPT
|
$ 0.36 | -10.09 % | $ 26.4 K | Nasdaq Global Market | USA |
 |
Fortress Biotech
FBIO
|
$ 1.87 | -3.11 % | $ 52.2 M | Nasdaq Capital Market | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 10.12 | 0.4 % | $ 289 M | Nasdaq Capital Market | USA |
|
Foghorn Therapeutics
FHTX
|
$ 2.04 | 2.0 % | $ 128 M | Nasdaq Global Market | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 13.76 | 4.13 % | $ 11.5 B | NYSE |  India |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 9.91 | 0.71 % | $ 271 M | Nasdaq Global Market,SPB | Israel |
 |
Sanofi
SNY
|
$ 41.77 | 0.41 % | $ 51 B | Nasdaq Global Select Market | France |
 |
Arcutis Biotherapeutics
ARQT
|
$ 31.74 | 1.73 % | $ 4.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Geron Corporation
GERN
|
$ 1.15 | 2.23 % | $ 767 M | Nasdaq Global Select Market | USA |
 |
Gossamer Bio
GOSS
|
$ 9.2 | -4.27 % | $ 2.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Titan Pharmaceuticals
TTNP
|
- | -3.76 % | $ 3.47 M | Nasdaq Capital Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
ALX Oncology Holdings
ALXO
|
$ 1.14 | -2.56 % | $ 61.2 M | Nasdaq Global Select Market,SPB | USA |
 |
Heron Therapeutics
HRTX
|
$ 0.3 | -0.46 % | $ 50 M | Nasdaq Global Select Market,SPB | USA |
 |
Achieve Life Sciences
ACHV
|
$ 6.55 | 0.85 % | $ 286 M | Nasdaq Capital Market | USA |
 |
TCR2 Therapeutics
TCRR
|
- | - | $ 58.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 17.02 | 0.98 % | $ 2.29 B | Nasdaq Global Market | Canada |
 |
iBio
IBIO
|
$ 0.71 | -1.28 % | $ 73.9 M | NYSE American | USA |
 |
ImmuCell Corporation
ICCC
|
$ 10.21 | -0.37 % | $ 92.2 M | Nasdaq Global Select Market | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Inhibikase Therapeutics
IKT
|
$ 1.51 | -5.03 % | $ 148 M | Nasdaq Capital Market | USA |
 |
Immunome
IMNM
|
$ 17.89 | -0.54 % | $ 1.56 B | Nasdaq Global Select Market | USA |
|
TFF Pharmaceuticals
TFFP
|
- | -60.05 % | $ 125 K | Nasdaq Global Select Market | USA |
 |
InMed Pharmaceuticals
INM
|
$ 1.57 | 9.03 % | $ 6.54 M | Nasdaq Capital Market | Canada |
 |
Inovio Pharmaceuticals
INO
|
$ 0.88 | -1.82 % | $ 41.3 M | Nasdaq Global Select Market | USA |
 |
Innoviva
INVA
|
$ 21.06 | 1.91 % | $ 1.42 B | Nasdaq Global Select Market | USA |